Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001725663-26-000007

Chief Financial Officer gave up 1,733 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

WENTWORTH KORY JAMES · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-02 Shares withheld for taxes : show line 1 in the form −1,733 $7.14 $12,380 117,277 D
Loading xslF345X06/wk-form4_1788470155.xml…